Alkermes (ALKS) Common Equity (2010 - 2026)

Alkermes (ALKS) has 17 years of Common Equity data on file, last reported at $1.8 billion in Q1 2026.

• Common Equity for Q1 2026 came in at $1.8 billion, up 15.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 15.87% YoY), and the FY2025 annual result was $1.8 billion, up 24.19% from the prior year.
• Common Equity declined to $1.8 billion in Q1 2026 per ALKS's latest filing, from $1.8 billion in the prior quarter.
• Over five years, Common Equity peaked at $1.8 billion in Q4 2025 and troughed at $1.0 billion in Q1 2023.
• A 5-year average of $1.3 billion and a median of $1.3 billion in 2024 frame the typical range for Common Equity.
• The sharpest annual moves came in 2023 and 2025: Common Equity retreated 6.49% in 2023, then soared 34.16% in 2025.
• A 5-year view of Common Equity shows it stood at $1.0 billion in 2022, then advanced by 15.23% to $1.2 billion in 2023, then gained by 21.81% to $1.5 billion in 2024, then grew by 24.19% to $1.8 billion in 2025, then fell by 3.72% to $1.8 billion in 2026.
• Business Quant data shows ALKS's Common Equity at $1.8 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.7 billion in Q3 2025.